Supplementary Figure 4: N-RasG12D but not FLT3-ITD or Tet2 haploinsufficiency leads to HSC protection from ER stress-induced apoptosis.

a, Experimental scheme of the assay for results depicted in Figure 2a-e, b, Summary of the percentage of Annexin V positive cells in HSCs purified from 8-10 weeks old FLT3-ITD knock-in mice (FLT3-ITD/+) and sex-matched littermate control mice (+/+) and treated 18 hours of 0.6 μg/ml Tunicamycin(Tm) and 0.2 μM Thapsigargin (Tg) (n=3-5 biological replicates in 3 independent experiments). c, Summary of apoptosis analysis of HSCs from Mx1-cre-; Tet2fl/+ (+/+) or Mx1-cre+; Tet2fl/+ (fl/+) mice at least 2 weeks after 6 dose of pIpC injection, and treated with 18 hours of 0.6 μg/ml Tunicamycin(Tm) and 0.2 μM Thapsigargin (Tg) (n=3 biological replicates in 1 independent experiments). d, Experimental scheme of chimerism maintenance experiment for Figure 2f. 0.5 million bone marrow cells from Mx1-cre+; NrasG12D/+ (G12D/+) or control CD45.2 mice (2 weeks after pIpC injection) were transplanted with 0.5 million competitor (CD45.1) bone marrow cells into recipient mice. Six weeks after transplantation, transplant recipients were injected with 2 mg/kg LPS for 3 doses every other day and HSCs chimerism was analyzed 2-4 weeks after LPS injections. e, Experimental scheme of analysis in Col1α1-H2B-GFP; Rosa26-M2-rtTA mice. Mice were treated with doxycycline for 6 weeks to label HSCs with GFP, after which doxycycline water was removed to allow HSCs to dilute GFP signal upon cell division. GFPhigh and GFPlow HSCs (Gating strategy to separate GFPhigh and GFPlow HSCs is shown on the bottom right) were purified after 18 weeks off doxycycline and were treated with Tg or Tm for 18 hours. Data represent mean±s.d. for panels b and c. Two-sided student t-test was used for statistical analysis.